Fidelity Investments
ANRO icon

Fidelity Investments’s Alto Neuroscience ANRO Stock Holding History

Fidelity Investments’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$142K Sell
6,314
-60
-0.9% -$1.11K ﹤0.01% 3650
2025
Q4 		$113K Sell
6,374
-1,302
-17% -$16.4K ﹤0.01% 3694
2025
Q3 		$30.9K Sell
7,676
-621
-7% -$2.06K ﹤0.01% 4175
2025
Q2 		$18.3K Sell
8,297
-1,264,389
-99% -$3.01M ﹤0.01% 4322
2025
Q1 		$2.75M Buy
1,272,686
+7,140
+0.6% +$25.6K ﹤0.01% 2345
2024
Q4 		$5.35M Sell
1,265,546
-1,097,510
-46% -$6.85M ﹤0.01% 2130
2024
Q3 		$27M Buy
2,363,056
+32,040
+1% +$392K ﹤0.01% 1611
2024
Q2 		$24.9M Sell
2,331,016
-18,900
-0.8% -$246K ﹤0.01% 1569
2024
Q1 		$36.1M Buy
+2,349,916
New +$36.8M ﹤0.01% 1450

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fidelity Investments's ANRO Position: Q1 2026 in Review

Fidelity Investments reduced its Alto Neuroscience (ANRO) stake by 0.94% in Q1 2026, selling an estimated $1.11K and leaving 6,314 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #3650.

Fidelity Investments first reported a position in ANRO in Q1 2024 and has held it in 9 quarters since. The position peaked at $36.1M in Q1 2024. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • Fidelity Investments held 6,314 shares of Alto Neuroscience worth $142K as of Q1 2026.
  • Fidelity Investments sold 60 Alto Neuroscience shares in Q1 2026, an estimated $1.11K.
  • Alto Neuroscience made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #3650 holding.
  • Fidelity Investments first reported a position in Alto Neuroscience in Q1 2024 and has held it in 9 quarters since.
  • Fidelity Investments's Alto Neuroscience position peaked at $36.1M in Q1 2024.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.